Patents Assigned to DIABELOOP
  • Closed-loop blood glucose control systems and methods
    Patent number: 11484652
    Abstract: An automated closed-loop blood glucose control system comprises a continuous glucose-monitoring sensor (101), a subcutaneous insulin delivery device (103); and a controller (105) which determines a maximal allowable insulin injection amount and determines an insulin delivery control signal on the basis of the maximal allowable insulin injection amount and the quantity of insulin to inject.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: November 1, 2022
    Assignee: DIABELOOP
    Inventors: Sylvain Rousson, Romain Blanc, Maeva Doron